MPA | Pharmacy News

S. 3308/H.R. 5951, the Improving Transparency and Accuracy in Medicare Part D Spending Act, was introduced in Congress earlier this year. This legislation aims to curb retroactive direct and indirect remuneration (DIR) fees imposed by pharmacy benefit managers (PBMs) in Medicare Part D. The lag time in the assessment of DIRs often times brings an unnecessary burden on the pharmacy as it is difficult to make decisions when pharmacies aren’t sure of how much payment will be received and when. This act will allow greater transparency in drug pricing, lower cost-sharing for beneficiaries and improve the overall integrity and operation of Medicare Part D program. This act aims to not increase the Medicare Part D costs and will not obstruct “pay for performance” programs.

MPA will be monitoring the status of these bills, as well as others, as it progresses through the legislature. For more information regarding these bills, as well as our our priorities and talking points, feel free to visit

Bookmark and Share  

Search for
Pharmacy News